Outpatient antibiotic consumption fluctuations in a view of unreasonable antibacterial therapy

• Autorzy: Ciszewski M. , Czekaj T. , Szewczyk E.M.
• Języki publikacji: EN

Abstrakty

EN

Unreasonable antibacterial therapy is suspected to be the main reason of emergence of multi-resistant bacteria. The connection between seasonal variability of antibiotic use and reasonable antibacterial therapy has been described. We examined the issue basing on the data obtained from the primary care system in Szczecin (Poland) in order to verify the situation in this region of Central Europe. Increase in antibiotic consumption in a viral infection season was proved to be statistically significant. Statistically significant differences in various drug forms dispensation were also observed. Increased consumption of antibiotics in seasons of influenza-like illnesses might be connected with a lack of proper diagnostics or numerous cases of bacterial co-infections.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2017
• Tom: 66
• Numer: 1
• Opis fizyczny: p.119-123,fig.,ref.

Twórcy

autor

Ciszewski M.

• Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, Lodz, Poland

autor

Czekaj T.

• Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, Lodz, Poland

autor

Szewczyk E.M.

• Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, Lodz, Poland

Bibliografia

• Ambur O.H., T. Davidsen, S.A. Frye, S.V. Balasingham, K. Lagesen, T. Rognes and T. Tønjum. 2009. Genome dynamics in major bacterial pathogens. FEMS Microbiol. Rev. 33: 453–470.
• Aminov R.I. 2010. A brief history of the antibiotic era: lessons learned and challenges for the future. Front. Microbiol. 1: 134.
• Bollaerts K., J. Antoine, V. Van Casteren, G. Ducoffre, N. Hens and S. Quoilin. 2013. Contribution of respiratory pathogens to influenza-like illness consultations. Epidemiology and Infection 141: 2196–2204.
• Centers for Disease Control and Prevention (CDC). 2014. Get smart: know when antibiotics work. http://www.cdc.gov/getsmart/ campaign-materials/adult-treatment.html, 2016.07.01.
• Central Statistical Office. 2013. Population in Poland. Size and structure by territorial division. As of June 30, 2013. Warsaw.
• Cobb G.W. 1998. Introduction to design and analysis of experiments. 1st ed. Springer-Verlag, New York.
• Davies J. 2014. Antibiotic resistance and the golden age of microbiology. Upsala Journal of Medical Sciences 119: 65–67.
• European Centre for Disease Prevention and Control (ECDC). 2013a. Geographical distribution of antimicrobial consumption of antibacterials for systemic use (ATC Group J01) in the community (Primary Care Sector) in Europe, reporting year 2012. http://www. ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/geo-distribution-consumption.aspx, 2016.07.01.
• European Centre for Disease Prevention and Control (ECDC). 2013b. Consumption of antimicrobials of antibacterials for systemic use (ATC Group J01) in the community (Primary Care Sector) in Europe, reporting year 2012. http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/Antimicrobial-consumption-rates-by-country.aspx, 2016.07.01
• European Centre for Disease Prevention and Control (ECDC). 2014. Antimicrobial Resistance and Healthcare-Associated Infections Programme. http://www.ecdc.europa.eu/en/activities/diseaseprogrammes/ARHAI/Pages/index.aspx, 2016.07.01
• Godycki-Cwirko M., J.W. Cals, N. Francis, T. Verheij, C.C. Butler, H. Goossens, I. Zakowska and L. Panasiuk. 2014. Public beliefs on antibiotics and symptoms of respiratory tract infections among rural and urban population in Poland: a questionnaire study. PloS One 9: e109248.
• Goossens H., M. Ferech, R.V. Stichele and M. Elseviers. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579–587.
• Grimaldi-Bensouda L., B. Bégaud, M. Rossignol, B. Avouac, F. Lert, F. Rouillon, J. Bénichou, J. Massol, G. Duru, A.M. Magnier and others. 2014. Management of upper respiratory tract infections by different medical practices, including homeopathy, and consumption of antibiotics in Primary Care: The EPI3 cohort study in France 2007–2008. PloS One 9: e89990.
• Hryniewicz W. 2011. Antibiotic resistance – What We have to do now? (in Polish). Polski Merkuriusz Lekarski 30: 305–309.
• Humphreys G. 2011. Are antibiotics still ‘automatic’ in France? Bulletin of the World Health Organization 89:8–9.
• Jennings L.C., T.P. Anderson, K.A. Beynon, A. Chua, R.T. Laing, A.M. Werno, S.A. Young, S.T. Chambers and D.R. Murdoch. 2008. Incidence and characteristics of viral community-acquired Pneumonia in adults. Thorax 63: 42–48.
• Ko S., J.W. Jang, D.J. Song, C.S. Lim and W.J. Kim. 2013. Evaluation of the Simplexa Flu A / B and RSV test for the rapid detection of influenza viruses. J. Med. Vir. 85: 2160–2164.
• Korppi M., A. Kotaniemi-Syrjänen, M. Waris, R. Vainionpää and T.M. Reijonen. 2004. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. The Pediatric Infectious Disease Journal 23: 995–999.
• L’Agence nationale de sécurité du médicament et des produits de santé. 2003. Systemic antibiotic treatment in upper and lower respiratory tract infections: Official French Guidelines. Clin. Microbiol. Infect. 9: 1162–78.
• Lean W.L., S. Arnup, M. Danchin and A.C. Steer. 2014. Rapid diagnostic tests for Group A streptococcal pharyngitis: a meta-analysis. Pediatrics 134: 771–781.
• Macfarlane J., W. Holmes, P. Gard, R. Macfarlane, D. Rose, V. Weston, M. Leinonen, P. Saikku and S. Myint. 2001. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 56: 109–114.
• Malmvall B.E., S. Mölstad, J. Darelid, A. Hiselius, L. Larsson, J. Swanberg and P.E. Abom. 2007. Reduction of antibiotics sales and sustained low incidence of bacterial resistance: report on a broad approach during 10 years to implement evidence-based indications for antibiotic prescribing in Jönköping County, Sweden. Quality Management in Health Care 16: 60–67.
• Mazińska B. and W. Hryniewicz. 2010. European Antibiotic Awareness Day Educational Campaign – Has it changed public attitudes to antibiotic use in Poland? (in Polish) Polski Merkuriusz Lekarski 29: 296–303.
• National Institute of Allergy and Infectious Diseases. 2014. NIAID’S Antibacterial Resistance Program: current status and future directions. http://www.niaid.nih.gov/topics/antimicrobialresistance/ documents/arstrategicplan2014.pdf, 2016.07.01.
• National Medicines Institute. 2010. Guidance for clinicians on the management of out-of-hospital respiratory tract infections (in Polish). http://www.antybiotyki.edu.pl/pdf/RekomendacjeA42009.pdf, 2016.07.01.
• National Medicines Institute. 2014. Polish National Antimicrobial Surveillance Program (in Polish). http://www.antybiotyki.edu.pl, 2016.07.01.
• Panasiuk L., W. Lukas, P. Paprzycki, T. Verheij, M. Godycki-Ćwirko and S. Chlabicz. 2010. Antibiotics in the treatment of upper respiratory tract infections in Poland. Is there any improvement? Journal of Clinical Pharmacy and Therapeutics 35: 665–669.
• Slinger R., R. Milk, I. Gaboury and F. Diaz-Mitoma. 2004. Evaluation of the QuickLab RSV Test, a new rapid lateral-flow immunoassay for detection of respiratory syncytial virus antigen. J. Clin. Microbiol. 42: 3731–3733.
• World Health Organisation (WHO). 2014a. Antimicrobial resistance: global report on surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/, 2016.07.01.
• World Health Organisation (WHO). 2014b. ATC/DDD Index 2014. http://www.whocc.no/atc_ddd_index/, 2016.07.01.

Identyfikatory

DOI

10.5604/17331331.1235000